Zdrowie i gospodarka · 06/05/2005
FDA Hosts Public Workshop on Rare Plasma Protein Disorders Treatment
The FDA is hosting a public workshop to discuss the development of biological products for treating rare plasma protein disorders, with a focus on scientific and regulatory challenges and potential future product development options.